TPG Telecom
TPG
$46.52
+0.11%
TPG Inc. is an alternative asset management firm operating across five multi-product platforms — Capital, Growth, Impact, Real Estate, and Market Solutions — with the addition of TPG Angelo Gordon extending its reach into credit and real estate strategies. The firm is a diversified global alternative manager with roughly $9 billion in market capitalization and about 1,900 employees, positioning it as a mid-sized peer to giants like Blackstone and KKR rather than a top-tier platform. The current investor narrative centers on the firm's aggressive deal-making — most notably the $18 billion take-private of Hologic alongside Blackstone — and on the sharp swing in quarterly results, with Q1 2026 revenue collapsing 33.25% year-over-year to $496 million and EBITDA turning negative. Debate is split between bulls who see a depressed earnings base masking strong fee-related earnings and a deep valuation discount, and bears who point to elevated leverage, a 1.45 beta, and a stock that has badly lagged the market over the past year.…
TPG
TPG Telecom
$46.52
Related headlines
TPG 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on TPG Telecom's 12-month outlook, with a consensus price target around $60.44 and implied upside of +29.9% versus the current price.
Average Target
$60.44
0 analysts
Implied Upside
+29.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$46 - $68
Analyst target range
Coverage is solid with 16 analysts, and sentiment leans bullish: the consensus recommendation is "buy" with a recommendation mean of 1.75 (where 1 is strong buy and 5 is strong sell), and the average target price is $60.44. Against the current price of $47.69, that implies upside of approximately 26.7% to the consensus target, a meaningful gap that suggests the sell-side sees the recent pullback as overdone. The distribution of recent institutional ratings is overwhelmingly constructive — BMO Capital (Outperform), Citizens (Market Outperform), Barclays (Overweight), UBS (Buy), and Goldman Sachs (Buy) have all reiterated positive ratings in 2026, with only TD Cowen (Hold) and Evercore ISI (In Line) sitting on the sidelines.\n\nThe target range is wide, from a low of $46.00 to a high of $68.00, a spread of $22.00 or roughly 48% of the low target — signaling meaningful disagreement about the earnings recovery trajectory. The low target of $46.00 is essentially at the current price, implying that the most cautious analyst sees no upside and prices in continued margin pressure and weak realizations; the high target of $68.00 implies roughly 42.6% upside and assumes a sharp rebound in incentive fees, successful deployment of the Hologic take-private and other flagship funds, and multiple expansion back toward peer levels. The wide spread, combined with the fact that no analyst has a sell rating, suggests the bear case is about timing and magnitude of the recovery rather than existential risk — but the dispersion also means position sizing should account for the possibility that the stock trades sideways for several quarters before the earnings inflection materializes.
Drowning in data?
Find the real signal!
Bulls vs Bears: TPG Investment Factors
The bull case rests on a deep valuation discount (forward PE of 13.15x), a 26.7% upside to the consensus target of $60.44, and the expectation that earnings normalize sharply from a depressed base. The bear case highlights a 33.25% revenue decline, negative EBITDA, a 665.8% payout ratio, and a 1.45 beta that amplifies market volatility. Currently, the bear evidence is stronger on reported financials, but the bull case is supported by analyst sentiment and the forward earnings recovery narrative. The single most important tension is whether incentive fees and realizations rebound in the next few quarters; if they do, the stock could re-rate toward peer multiples, but if they remain weak, the dividend and leverage become pressing concerns.
Bullish
- Deep discount to analyst targets: The consensus average target price is $60.44 versus the current $47.69, implying 26.7% upside. With 16 analysts covering and a recommendation mean of 1.75 (buy), the sell-side sees the recent pullback as overdone.
- Forward PE of 13.15x is undemanding: The forward PE of 13.15x is well below the high-teens to low-twenties multiple typical of alternative asset managers. Analyst EPS estimates of $4.78 for the forward year imply earnings roughly triple from the current depressed base.
- High gross margin and strong FCF: Gross margin remains exceptionally high at 96.9%, and trailing twelve-month free cash flow is $972 million. Q1 2026 operating cash flow was $176.6 million with FCF of $160.3 million, demonstrating the asset-light model's cash generation.
- Massive deal pipeline and platform expansion: TPG is participating in the $18 billion take-private of Hologic alongside Blackstone, and the addition of TPG Angelo Gordon extends its reach into credit and real estate. These deals should drive fee-related earnings and future carry.
Bearish
- Revenue collapse and negative EBITDA: Q1 2026 revenue fell 33.25% year-over-year to $496 million, and EBITDA turned negative at -$66.2 million. Net income swung to a loss of -$1.45 million from +$25.4 million a year earlier.
- Unsustainable dividend and payout ratio: The dividend yield of 13.86% is extraordinarily high and reflects the depressed share price, not a sustainable payout. The payout ratio is 665.8%, meaning the company pays out far more than it earns.
- Elevated leverage and weak liquidity: Debt-to-equity is 1.45x and the current ratio is a strikingly low 0.15. The company returned $326.9 million in dividends and repurchased $209 million of stock in Q1 while repaying $625 million of debt, exceeding its cash generation.
- High beta and severe underperformance: Beta of 1.45 means TPG is 45% more volatile than the S&P 500. The stock is down 23.19% over the past year and 27.47% year-to-date, with a 1-year relative strength of -39.41 points versus SPY.
TPG Technical Analysis
TPG is in a recovery phase within a broader downtrend: the shares are down 23.19% over the past year and 27.47% year-to-date, yet have rallied 17.75% over six months and 10.88% over three months. At $47.69, the stock sits at roughly 31.9% of its 52-week range (low $36.95, high $70.38), which places it in the lower third of the band — closer to value-territory than momentum-extension, but still well below the highs that would confirm a durable trend reversal. The 45.55% maximum drawdown underscores how violent the prior decline was, and the current bounce should be treated as a counter-trend recovery until proven otherwise.\n\nShort-term momentum has turned sharply negative and is diverging from the improving medium-term trend: the stock is down 6.27% over the past month versus a 10.88% gain over three months and a 17.75% gain over six months. That divergence — a strong 3-6 month recovery interrupted by a weak 1-month pullback — suggests profit-taking after the August spike rather than a full trend reversal, though the magnitude of the recent slide (from $55.21 on August 13 to $47.69 on September 11, a 13.6% drop) is a warning. Relative strength confirms the deterioration: TPG underperformed SPY by 5.21 percentage points over the past month even as it outperformed by 7.84 points over three months, and the 1-year relative strength of -39.41 points shows how deeply the stock has lagged the market. Volume of 3.14 million shares on the latest session is unremarkable, offering no capitulation signal.\n\nKey technical levels are clear: support sits at the 52-week low of $36.95, roughly 22.5% below the current $47.69 price, while resistance is the 52-week high of $70.38, about 47.6% above. A breakout above the August high of $55.21 would signal that the recovery has legs and could open a path toward the $60s; a breakdown below the $46.93 previous close and then the $44-45 area would risk a retest of the $40 round number and ultimately the $36.95 low. With a beta of 1.45, TPG is 45% more volatile than the S&P 500, meaning position sizing should be materially smaller than a market-beta equivalent and stop-losses should be wider to avoid noise-driven exits.
Beta
1.45
1.45x market volatility
Max Drawdown
-45.5%
Largest decline past year
52-Week Range
$37-$70
Price range past year
Annual Return
-27.2%
Cumulative gain past year
| Period | TPG Return | S&P 500 |
|---|---|---|
| 1m | -11.2% | +1.0% |
| 3m | +17.5% | +5.4% |
| 6m | +14.3% | +17.8% |
| 1y | -27.2% | +16.5% |
| ytd | -29.2% | +13.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
TPG Fundamental Analysis
TPG's revenue trajectory is highly volatile and currently deteriorating on a reported basis: Q1 2026 revenue was $496.15 million, down 33.25% year-over-year from $743.33 million in Q1 2025, and down sharply from $1.49 billion in Q4 2025. The sequential collapse reflects the lumpy nature of performance and incentive fees in alternative asset management, but the year-over-year decline is real and concerning. Segment data shows the revenue base is dominated by management fees of $479.43 million, supplemented by transaction fees of $64.92 million, expense reimbursements of $57.40 million, monitoring fees of $10.07 million, and incentive fees of just $8.21 million — the near-absence of incentive fees in the quarter is the key swing factor, and the investment case hinges on whether realizations and carry rebound.\n\nProfitability has swung to a loss: Q1 2026 net income was -$1.45 million versus +$25.39 million in Q1 2025, with operating income of -$120.32 million and EBITDA of -$66.23 million. Gross margin remains exceptionally high at 83.17% (versus 96.76% in the year-ago quarter), which is typical for an asset-light manager, but the operating margin of -24.25% shows how quickly compensation and other expenses overwhelm a shrunken revenue base. The trailing net margin is just 3.95% and the operating margin 14.68%, both thin for the sector, and the Q1 loss marks a sharp reversal from the 5.17% net margin posted in Q4 2025. The path back to profitability depends on fee-related earnings holding up while carry and realizations normalize.\n\nThe balance sheet carries meaningful leverage and weak near-term liquidity optics: debt-to-equity is 1.45x, the current ratio is a strikingly low 0.15, and ROE is 15.57% on a trailing basis. Free cash flow is a bright spot at $972.04 million on a trailing twelve-month basis, and Q1 2026 operating cash flow was $176.55 million with FCF of $160.28 million, but the company returned $326.93 million in dividends and repurchased $208.96 million of stock in the quarter — more than it generated — while also repaying $625 million of debt. Cash at period end was $864.65 million, up from $839.27 million, but the low current ratio and 1.45x leverage mean TPG depends on continued fee generation and capital markets access to fund its distribution policy, which carries a payout ratio of 665.8% and a dividend yield of 13.86%.
Quarterly Revenue
$496151000.0B
2026-03
Revenue YoY Growth
-33.3%
YoY Comparison
Gross Margin
83.2%
Latest Quarter
Free Cash Flow
$972036000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is TPG Overvalued?
Because TPG's trailing net income is positive but razor-thin (EPS of $0.02), the trailing PE of 48x is distorted and not the most informative metric; the forward PE of 13.15x is far more meaningful and reflects the market's expectation that earnings normalize sharply. The enormous gap between the 48x trailing and 13.15x forward multiple implies the market expects earnings to roughly triple, consistent with analyst EPS estimates of $4.78 for the forward year versus the current depressed base. On a price-to-sales basis, TPG trades at 1.90x, and EV/Sales is 2.68x, both of which are more stable anchors given the volatility of reported earnings.\n\nRelative to the asset management sector, TPG screens as a mixed picture: the 1.90x PS ratio is modest for an alternative manager with high gross margins (96.90%) and a 15.57% ROE, while the 7.48x price-to-book is rich versus the 4.3-5.7x book multiples the stock traded at in 2022-2023. The forward PE of 13.15x is undemanding in absolute terms and likely below the broader alternative asset management peer group, which typically trades in the high-teens to low-twenties forward earnings multiple — implying TPG is at a discount on forward earnings but a premium on book value. The PEG ratio of 0.10 is extremely low, but it is distorted by the depressed trailing earnings base and should not be taken at face value.\n\nHistorically, TPG's valuation has compressed dramatically: the PS ratio was 13.03x in Q1 2026 (on a collapsed revenue base), 6.58x in Q4 2025, and 10.29x in Q3 2025, versus the current 1.90x — though these historical figures are distorted by the revenue collapse and should be read with caution. The price-to-book of 7.48x is near the upper end of its own historical band (4.33x in Q4 2022, 8.54x in Q4 2024, 8.28x in Q4 2025), suggesting the market is pricing in a recovery in book value and earnings. The dividend yield of 13.86% is extraordinarily high and reflects the depressed share price rather than a sustainable payout, given the 665.8% payout ratio — investors should treat the yield as a warning sign, not an income opportunity.
PE
48.0x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 0x~148x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
27.5x
Enterprise Value Multiple
Investment Risk Disclosure
TPG faces significant financial and operational risks. The company's Q1 2026 revenue collapsed 33.25% year-over-year to $496 million, with EBITDA turning negative at -$66.2 million and net income swinging to a loss of -$1.45 million. The near-absence of incentive fees ($8.2 million) highlights the lumpy and unpredictable nature of performance fees, which are critical to profitability. Furthermore, debt-to-equity of 1.45x and a current ratio of 0.15 indicate elevated leverage and weak short-term liquidity, while the 665.8% payout ratio and 13.86% dividend yield suggest the distribution policy is unsustainable without a sharp earnings recovery. The company returned $326.9 million in dividends and repurchased $209 million of stock in Q1, exceeding its free cash flow of $160.3 million, which raises concerns about capital allocation and balance sheet flexibility.
Market and competitive risks are also pronounced. TPG trades at a forward PE of 13.15x, which is below the high-teens to low-twenties multiple typical of alternative asset managers, but this discount may persist if earnings fail to recover. The stock's beta of 1.45 makes it highly sensitive to market downturns, and its 1-year relative strength of -39.41 points versus SPY underscores severe underperformance. Competitive pressures from larger peers like Blackstone and KKR, which have greater scale and diversified revenue streams, could limit TPG's ability to win large deals and attract capital. Additionally, regulatory headwinds in private equity and credit markets, as well as potential changes in tax treatment of carried interest, pose ongoing threats. Recent news of the $18 billion Hologic take-private alongside Blackstone is a positive, but it also concentrates risk in a single large deal and may strain resources.
The worst-case scenario involves a continued decline in incentive fees and realizations, leading to sustained negative EBITDA and a liquidity crunch. If the company is forced to cut its dividend, the stock could plummet toward its 52-week low of $36.95, representing a 22.5% downside from the current $47.69. The analyst low target of $46.00 is only slightly below the current price, but in a severe downturn, the stock could retest the $36.95 low, implying a loss of approximately 22.5%. The maximum drawdown over the past year was 45.55%, so a similar decline from current levels would take the stock to around $26, though that is an extreme scenario. A more realistic bear case sees the stock trading in the low $40s if earnings disappoint, a decline of 10-15%.
